Letters to the Editor

Favorable pharmacokinetic and pharmacodynamic properties of gilteritinib in cerebrospinal fluid: a potential effective treatment in relapsing meningeal acute myeloid leukemia FLT3-ITD patients

AP-HP, Hôpital Saint-Louis, Department of Pharmacology, Paris, France; INSERM U976, Université Paris Cité, Paris
INSERM U944, Université Paris-Cité, Paris
AP-HP, Hôpital Saint-Louis, Department of Haematology, Paris
CH Versailles, Department of Haemato-Oncology, Versailles
AP-HP, Hôpital Avicenne, Department of Haematology, Paris
IGR, Department of Haematology, Villejuif
AP-HP, Hôpital Saint-Louis, Department of Pharmacology, Paris, France; INSERM U976, Université Paris Cité, Paris
AP-HP, Hôpital Avicenne, Department of Haematology, Paris
AP-HP, Hôpital Saint-Louis, Department of Pharmacology, Paris
CH Versailles, Department of Haemato-Oncology, Versailles
CH Versailles, Department of Haemato-Oncology, Versailles
INSERM U944, Université Paris-Cité, Paris
AP-HP, Hôpital Saint-Louis, Department of Haematology, Paris
AP-HP, Hôpital Saint-Louis, Department of Pharmacology, Paris, France; INSERM U976, Université Paris Cité, Paris
AP-HP, Hôpital Saint-Louis, Department of Pharmacology, Paris, France; INSERM U976, Université Paris Cité, Paris
Vol. 108 No. 9 (2023): September, 2023 https://doi.org/10.3324/haematol.2022.282596